[go: up one dir, main page]

NO993650L - New compounds with hemoregulatory effect - Google Patents

New compounds with hemoregulatory effect

Info

Publication number
NO993650L
NO993650L NO993650A NO993650A NO993650L NO 993650 L NO993650 L NO 993650L NO 993650 A NO993650 A NO 993650A NO 993650 A NO993650 A NO 993650A NO 993650 L NO993650 L NO 993650L
Authority
NO
Norway
Prior art keywords
hemoregulatory
effect
new compounds
compounds
formula
Prior art date
Application number
NO993650A
Other languages
Norwegian (no)
Other versions
NO993650D0 (en
Inventor
Johann Hiebl
Hermann Kollmann
Franz Rovenszky
Michael Hartmann
Original Assignee
Nycomed Austria Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nycomed Austria Gmbh filed Critical Nycomed Austria Gmbh
Publication of NO993650L publication Critical patent/NO993650L/en
Publication of NO993650D0 publication Critical patent/NO993650D0/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81—Amides; Imides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/45—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups
    • C07C233/46—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
    • C07C233/47—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom having the carbon atom of the carboxamide group bound to a hydrogen atom or to a carbon atom of an acyclic saturated carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06—Esters of carbamic acids
    • C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C271/22—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by carboxyl groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06139—Dipeptides with the first amino acid being heterocyclic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Pyridine Compounds (AREA)

Abstract

Oppfinnelsen angår nye forbindelser med formel I, som har hemoregulatorisk virkning, anvendelse av disse og en fremgangsmåte for fremstilling av forbindelsene.The invention relates to novel compounds of formula I which have a hemoregulatory effect, their use and a process for the preparation of the compounds.

NO993650A 1997-01-27 1999-07-27 New compounds with hemoregulatory effect NO993650D0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AT10797 1997-01-27
PCT/EP1998/000511 WO1998032738A1 (en) 1997-01-27 1998-01-27 New compounds with hemoregulating effect

Publications (2)

Publication Number Publication Date
NO993650L true NO993650L (en) 1999-07-27
NO993650D0 NO993650D0 (en) 1999-07-27

Family

ID=3481709

Family Applications (2)

Application Number Title Priority Date Filing Date
NO993650A NO993650D0 (en) 1997-01-27 1999-07-27 New compounds with hemoregulatory effect
NO993782A NO993782D0 (en) 1997-01-27 1999-08-04 New compounds with hemoregulatory effect

Family Applications After (1)

Application Number Title Priority Date Filing Date
NO993782A NO993782D0 (en) 1997-01-27 1999-08-04 New compounds with hemoregulatory effect

Country Status (4)

Country Link
EP (1) EP0958283A1 (en)
JP (1) JP2001509795A (en)
NO (2) NO993650D0 (en)
WO (1) WO1998032738A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ300780B6 (en) 1998-07-16 2009-08-12 Sanofi - Aventis Deutschland GmbH Derivatives of phosphinic and phosphonic acids, process of their preparation and medicament in which they are comprised

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9425730D0 (en) * 1994-12-20 1995-02-22 Nycomed Pharma As Compounds
EP0866698A4 (en) * 1995-11-13 1999-03-03 Smithkline Beecham Corp Hemoregulatory compounds
EP0861080A4 (en) * 1995-11-13 1999-01-20 Smithkline Beecham Corp Hemoregulatory compounds
JP2000500462A (en) * 1995-11-13 2000-01-18 スミスクライン・ビーチャム・コーポレイション Blood regulatory compounds
WO1997017850A1 (en) * 1995-11-13 1997-05-22 Smithkline Beecham Corporation Hemoregulatory compounds
JP2000500750A (en) * 1995-11-13 2000-01-25 スミスクライン・ビーチャム・コーポレイション Blood regulatory compounds

Also Published As

Publication number Publication date
NO993650D0 (en) 1999-07-27
NO993782D0 (en) 1999-08-04
WO1998032738A1 (en) 1998-07-30
JP2001509795A (en) 2001-07-24
EP0958283A1 (en) 1999-11-24

Similar Documents

Publication Publication Date Title
NO20050199L (en) Azadicyclooctane and nonander derivatives with DDP-IV inhibitory activity
DE69729583D1 (en) N- (AMIDINOPHENYL) -N '- (SUBST.) - 3H-2,4-BENZODIAZEPIN-3-ON DERIVATIVE AS FACTOR XA INHIBITORS
DK1200418T3 (en) Nematodicidal trifluorobutene
NO992821L (en) Ketobenzamides as Calpain Inhibitors
NO971684L (en) New benzoxazoles
NO963370L (en) Novel mercaptoacetylamido-1,3,4,5-tetrahydrobenzo [cazazepin-3-one disulfide derivatives useful as inhibitors of enkephalinase and ACE
NO20062021L (en) Redirected pentanols, their methods of preparation, and their use as antiflogistics
PT923554E (en) N-BENZYLPIPERIDINE AND TETRAHYDROPYRIDINE DERIVATIVES
NO20052884L (en) Substituted indolpyridine compounds as anti-infective agents.
DK1100789T3 (en) Substituted benzoylcyclohexanedions
NO971625L (en) Novel peptides with immunomodulatory effects
DK0828721T3 (en) 2-Aminobenzoxazinones for the treatment of viral infections
NO981393L (en) Guanidinoproteasehemmere
ES2194102T3 (en) NEW N- (2,4-DIOXO-2,3,4,5-TETRAHIDRO-1H-1,5-BENZODIAZEPIN-3-IL) -3-AMIDAS.
NO20016151L (en) Preparation of substituted piperidin-4-ones
SE9604582D0 (en) Novel compounds
NO943765L (en) Aryloksybenzen-herbicidmidler
NO993650L (en) New compounds with hemoregulatory effect
IL158356A0 (en) Benzoheterocycles
ATE242763T1 (en) METHOXIMINOPHENYLACETIC ACID AMIDES
NO962620L (en) New intermediates for the synthesis of L-aspartyl-D - aminoalkanoyl- (S) -N - alkylbenzylamides useful as artificial sweeteners
DE59803066D1 (en) SUBSTITUTED BENZYLOXYIMINO COMPOUNDS
CO5150221A1 (en) NEW 3-PHENOXI- AND 3-PHENYLALQUILOXI-2-PHENYL-SUBSTITUTED PROPILAMINS
NO20014937D0 (en) Natural pseudomycin products
MX9709016A (en) 2-amino-benzoxazinones for the treatment of viral infections.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application